The committee voted 16 to 1 that available data support the safety and effectiveness of Paxlovid for treating mild to moderate COVID-19 in adult patients at high risk for progression to severe illness.
Altuviiio is an injectable medicine used to control and reduce the number of bleeding episodes in people with hemophilia A (congenital Factor VIII deficiency).
Lilly also will automatically cap out-of-pocket costs at $35 at participating retail pharmacies for people with commercial insurance using Lilly insulin.